BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7601398)

  • 21. A new class of defective hepatitis B virus genomes with an internal poly(dA) sequence.
    Sommer G; Günther S; Sterneck M; Otto S; Will H
    Virology; 1997 Dec; 239(2):402-12. PubMed ID: 9434730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
    Sagnelli E; Coppola N; Messina V; Di Caprio D; Marrocco C; Marotta A; Onofrio M; Scolastico C; Filippini P
    Hepatology; 2002 Nov; 36(5):1285-91. PubMed ID: 12395342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
    Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti-hepatitis B e-positive chronic hepatitis.
    Dienes HP; Gerken G; Goergen B; Heermann K; Gerlich W; Meyer zum Büschenfelde KH
    Hepatology; 1995 Jan; 21(1):1-7. PubMed ID: 7806140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
    Ozasa A; Tanaka Y; Orito E; Sugiyama M; Kang JH; Hige S; Kuramitsu T; Suzuki K; Tanaka E; Okada S; Tokita H; Asahina Y; Inoue K; Kakumu S; Okanoue T; Murawaki Y; Hino K; Onji M; Yatsuhashi H; Sakugawa H; Miyakawa Y; Ueda R; Mizokami M
    Hepatology; 2006 Aug; 44(2):326-34. PubMed ID: 16871568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
    J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.
    Wang YL; Liou GG; Lin CH; Chen ML; Kuo TM; Tsai KN; Huang CC; Chen YL; Huang LR; Chou YC; Chang C
    PLoS One; 2015; 10(3):e0119625. PubMed ID: 25785443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between amount of HBV DNA in serum/liver tissue and hepatitis G virus (HGV) infection in patients with chronic hepatitis B].
    Shang Q; Yu J; Zhuo H; Xu C; Wang N; Zhang G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):326-8. PubMed ID: 12665896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis.
    Märschenz S; Endres AS; Brinckmann A; Heise T; Kristiansen G; Nürnberg P; Krüger DH; Günther S; Meisel H
    Gastroenterology; 2006 Sep; 131(3):765-80. PubMed ID: 16952546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
    Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
    Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
    Liu CJ; Jeng YM; Chen CL; Cheng HR; Chen PJ; Chen TC; Liu CH; Lai MY; Chen DS; Kao JH
    J Infect Dis; 2009 Mar; 199(5):742-9. PubMed ID: 19199543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA.
    Köck J; Nassal M; Deres K; Blum HE; von Weizsäcker F
    J Virol; 2004 Dec; 78(24):13812-8. PubMed ID: 15564489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
    Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
    Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis revealed that conservation of hepatitis B virus reverse transcriptase residue 306 (rtP306) is crucial for encapsidation of pregenomic RNA.
    Wang YX; Xu X; Luo C; Ma ZM; Jiang HL; Ding JP; Wen YM
    FEBS Lett; 2007 Feb; 581(3):558-64. PubMed ID: 17254572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B doubly spliced protein, generated by a 2.2 kb doubly spliced hepatitis B virus RNA, is a pleiotropic activator protein mediating its effects via activator protein-1- and CCAAT/enhancer-binding protein-binding sites.
    Chen WN; Chen JY; Lin WS; Lin JY; Lin X
    J Gen Virol; 2010 Oct; 91(Pt 10):2592-600. PubMed ID: 20538904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.